CAMV
MDT icon

Concord Asset Management (Virginia)’s Medtronic MDT Stock Holding History

Concord Asset Management (Virginia)’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,990
Closed -$314K – 129
2024
Q2 		$314K Buy
+3,990
New +$327K 0.08% 120
2023
Q4 		– Sell
-3,644
Closed -$286K – 140
2023
Q3 		$286K Sell
3,644
-264
-7% -$22.1K 0.1% 109
2023
Q2 		$344K Buy
+3,908
New +$336K 0.12% 93

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Concord Asset Management (Virginia)'s MDT Position: Q3 2024 in Review

Concord Asset Management (Virginia) sold out of Medtronic (MDT) in Q3 2024, closing a stake of 3,990 shares — an estimated $314K sold.

Concord Asset Management (Virginia) first reported a position in MDT in Q2 2023 and held it in 3 quarters. The position peaked at $344K in Q2 2023. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

  • Concord Asset Management (Virginia) reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
  • Concord Asset Management (Virginia) sold 3,990 Medtronic shares in Q3 2024, an estimated $314K.
  • Concord Asset Management (Virginia) first reported a position in Medtronic in Q2 2023 and held it in 3 quarters.
  • Concord Asset Management (Virginia)'s Medtronic position peaked at $344K in Q2 2023.
  • 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on Concord Asset Management (Virginia)'s 13F filing for Q3 2024, filed 7 Nov 2024.